Company · CIK 0001113148
INFINITY PHARMACEUTICALS, INC.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- 8-KCurrent report0001113148-23-000018 · 166.8 KBSEC(opens sec.gov)
- 8-KCurrent report0001113148-23-000016 · 158.2 KBSEC(opens sec.gov)
- 8-KCurrent report0001113148-23-000014 · 161.0 KBSEC(opens sec.gov)
- 8-KCurrent report0001113148-23-000012 · 172.2 KBSEC(opens sec.gov)
- 10-QQuarterly update0001113148-23-000009 · 3.9 MBSEC(opens sec.gov)
- 8-KCurrent report0001140361-23-036062 · 188.4 KBSEC(opens sec.gov)
- 8-KCurrent report0001140361-23-035755 · 184.2 KBSEC(opens sec.gov)
- 8-KCurrent report0001140361-23-034615 · 173.7 KBSEC(opens sec.gov)
- 8-KCurrent report0001140361-23-032815 · 1.1 MBSEC(opens sec.gov)
- 8-KCurrent report0001140361-23-032462 · 172.5 KBSEC(opens sec.gov)
Insiders
- ADAMS JULIANPresident of R&D
- Agresta SamuelDirector
- Babler MartinDirector
- Baselga JoseDirector
- BEIER DAVID WDirector
- Berkowitz JeffreyDirector
- Bertrand William C JRGeneral Counsel
- BIOTECHNOLOGY VALUE FUND L PSee Explanation of Responses
- Biotechnology Value Trading Fund OS LPSee Explanation of Responses
- BLOCH LAWRENCE EPresident
Tickers
No tickers on record.
Addresses
business
1100 MASSACHUSETTS AVENUE FLOOR 4
CAMBRIDGE, MA, 02138
mailing
1100 MASSACHUSETTS AVENUE FLOOR 4
CAMBRIDGE, MA, 02138
Former names
- DISCOVERY PARTNERS INTERNATIONAL INC2006-09-11
Same industry